Syngene: Funding, Investors & Team (Aug 2026)
An integrated contract research, development, and manufacturing firm, Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) offers scientific services ranging from early discovery to commercial supply. We serve a wide range of industrial sectors, including those in the pharmaceutical, biotechnology, nutrition, animal health, consumer products, and specialty chemical industries, with our creative capabilities for novel molecular entities (NMEs). Early-stage research, from target identification to the delivery of therapeutic candidates for future development, is one of our discovery services. Development services cover pre-clinical and clinical trial activities such as Drug Substance Development (DSP), Drug Product Development (DPD), and related services to prove the safety, tolerability, and efficacy of the chosen drug candidate.
Syngene has raised $145M across 1 funding round on record, the most recent an undisclosed round of $145M announced in Feb 2023.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Syngene Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Syngene Funding Rounds
Syngene Founders and Leadership Team
No contact details are on record for this team yet.
Syngene Funding Compared to Other Health Care Startups
Syngene's latest round of $145M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Syngene in Health Care and Bangalore
Companies Similar to Syngene
InstaAstro offers individual Astrology consultations, along with Daily Activity Tracks & Content, to assist…
Lissun is a comprehensive mental health and well-being platform that aims to offer mental health remedies to…
Fibroheal Woundcare Pvt Ltd focuses on leveraging silk proteins to create biomedical applications for…
Mykare Health is constructing the largest affordable and reliable hospital network in India. So far, Mykare…
SuperLiving is a lifestyle-tech platform designed for Bharat that aims to make everyday life more attentive…
QubeHealth is a healthcare payments company. Integrating a massive ‘payments infrastructure’ in India,…
Immuneel Therapeutics is a clinical-stage biotechnology company that develops cell and gene therapies focused…
MediElaj is a digital healthcare platform designed to provide accessible medical assistance through a mobile…
betterhood is an Indian wellness brand providing products for pain relief, posture support, and active living.
SS Innovations to improve gold standard surgical procedures through the union of great skill, patient care…
Pulse focuses on low and mid-complexity medical equipment and consumables categories where India has strong…
Syngene Funding FAQs
What does Syngene do?
An integrated contract research, development, and manufacturing firm, Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) offers scientific services ranging from early discovery to commercial supply. We serve a wide range of industrial sectors, including those in the pharmaceutical, biotechnology, nutrition, animal health, consumer products, and specialty chemical industries, with our creative capabilities for novel molecular entities (NMEs). Early-stage research, from target identification to the delivery of therapeutic candidates for future development, is one of our discovery services. Development services cover pre-clinical and clinical trial activities such as Drug Substance Development (DSP), Drug Product Development (DPD), and related services to prove the safety, tolerability, and efficacy of the chosen drug candidate.
How much funding has Syngene raised?
Syngene has raised $145M across 1 round on record. The most recent is an undisclosed round of $145M announced in Feb 2023.
When did Syngene last raise funding?
Syngene's most recent funding round on record is an undisclosed round of $145M, announced in Feb 2023.
Who is the CEO of Syngene?
Jonathan Hunt is listed as CEO at Syngene.
Where is Syngene headquartered?
Syngene is based in Bangalore, Karnataka, India.
How many employees does Syngene have?
Syngene is in the 1001-5000 employee band.
How does Syngene's funding compare to other Health Care startups?
Syngene's latest round of $145M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Syngene Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Syngene is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.